{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:07:14Z","timestamp":1760234834405,"version":"build-2065373602"},"reference-count":25,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,6,20]],"date-time":"2021-06-20T00:00:00Z","timestamp":1624147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Chemoembolization with irinotecan-loaded microspheres has proven effective in the treatment of unresectable liver metastases in the course of colorectal cancer (CRC). Most researchers recommend slowly administering the embolizate at the level of the lobar arteries, without obtaining visible stasis. However, there are reports of a relationship between postoperative embolizate retention in metastatic lesions and the response to treatment. To retain residual embolizate throughout the entire neoplastic lesion requires a temporary flow stop (stasis) within all supply vessels, which may cause temporary stasis in subsegmental or even segmental vessels. Objective: To assess the risk of complications and post-embolization syndrome severity following chemoembolization of CRC metastatic liver lesions with microspheres loaded with Irinotecan, with regard to hepatic-artery branch level of temporary stasis. Patients and methods: The study included 52 patients (29 female, 23 male) with liver metastases from CRC, who underwent 202 chemoembolization treatments (mean: 3.88 per patient) with microspheres loaded with 100 mg irinotecan. Postembolization syndrome (PES) severity and complication occurrence were assessed with regard to the hepatic-artery branch level of temporary stasis. Adverse events were assessed according to Cancer Therapy Evaluation Program Common Terminology Criteria for Adverse Events. Results: Median survival from the start of chemoembolization was 13 months. From 202 chemoembolization sessions, 15 (7.4%) significant complications were found. The study found a significant relationship between the branch level of temporary stasis and the presence of complications (p &lt; 0.001), with the highest number of complications observed with temporary stasis in segmental vessels. PES was diagnosed after 103 (51%) chemoembolization treatments. A significant association was found between PES severity and the branch level of temporary stasis (p &lt; 0.001). Conclusions: The branch level of temporary stasis affected the severity of post-embolization syndrome. A significant association was found between the branch level of temporary stasis obtained in chemoembolization procedures and the presence of complications. The apparent lack of change in numbers of complications when stasis was applied at tumor supply vessels or subsegmental arteries may indicate the safe use of temporary stasis in some cases where colorectal cancer metastases are treated. Further research is needed to determine the most effective chemoembolization technique.<\/jats:p>","DOI":"10.3390\/curroncol28030211","type":"journal-article","created":{"date-parts":[[2021,6,20]],"date-time":"2021-06-20T22:00:02Z","timestamp":1624226402000},"page":"2296-2307","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Complications Following Irinotecan-Loaded Microsphere Chemoembolization of Colorectal Metastatic Liver Lesions Associated with Hepatic-Artery Branch Temporary Stasis"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-7495","authenticated-orcid":false,"given":"Marcin","family":"Szemitko","sequence":"first","affiliation":[{"name":"Department of Interventional Radiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elzbieta","family":"Golubinska-Szemitko","sequence":"additional","affiliation":[{"name":"Department of General and Dental Diagnostic Imaging, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Sienko","sequence":"additional","affiliation":[{"name":"Department of General and Transplant Surgery, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander","family":"Falkowski","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10585-012-9551-8","article-title":"The tumour biology of synchronous and metachronous colorectal liver metastases: A systematic review","volume":"30","author":"Slesser","year":"2013","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0959-8049(02)00059-X","article-title":"Treatment of liver metastases, an update on the possibilities and results","volume":"38","author":"Ruers","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1245\/s10434-007-9522-5","article-title":"Simultaneous resections of colorectal cancer and synchronous liver metastases: A multi-institutional analysis","volume":"14","author":"Reddy","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"ref_4","first-page":"1387","article-title":"Intra-arterial infusion of irinotecan-loaded drug eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) forhepatic metastases from colorectal cancer: Final results of a phase III study","volume":"32","author":"Fiorentini","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00330-006-0372-5","article-title":"Colorectal liver metastases: Regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: An update","volume":"17","author":"Vogl","year":"2007","journal-title":"Eur. Radiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2019.05.021","article-title":"Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods","volume":"136","author":"Hagan","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_7","first-page":"7279163","article-title":"Does Tumour Contrast Retention on CT Immediately Post Chemoembolization Predict Tumour Metabolic Response on FDG-PET in Patients with Hepatic Metastases from Colorectal Cancer?","volume":"4","author":"Tan","year":"2019","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10585-019-09954-5","article-title":"Hepatic arterial infusion of irinotecan and EmboCept\u00ae S results in high tumor concentration of SN-38 in a rat model of colorectal liver metastases","volume":"36","author":"Kauffels","year":"2019","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jvir.2013.05.055","article-title":"Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: Systematic review","volume":"24","author":"Richardson","year":"2013","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1245\/s10434-010-1288-5","article-title":"Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: Results of multi-institutional study","volume":"18","author":"Martin","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00270-012-0394-0","article-title":"Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellularcarcinoma: Five-year survival analysis","volume":"35","author":"Malagari","year":"2012","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.jvir.2017.07.020","article-title":"Transarterial chemoembolization with small drug-eluting beads in patients with hepatocellular carcinoma: Experience from a cohort of 421 patients at an Italian center","volume":"28","author":"Aliberti","year":"2017","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jvir.2016.08.017","article-title":"Korean multicenter registry of transcatheter arterial chemoembolization with drug-eluting embolic agents for nodular hepatocellular carcinomas: Six-month outcome analysis","volume":"28","author":"Lee","year":"2017","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1515\/raon-2015-0045","article-title":"Survival of patients with intermediate stage hepatocellular carcinoma treated with superselective transarterial chemoembolization using doxorubicin-loaded DC Bead under cone-beam computed tomography control","volume":"50","author":"Popovic","year":"2016","journal-title":"Radiol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1148\/radiology.198.1.8539401","article-title":"Hepatic tumors: Predisposing factors for complications of transcatheter oily chemoembolization","volume":"198","author":"Chung","year":"1996","journal-title":"Radiology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-0031-1280666","article-title":"Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome","volume":"28","author":"Dhand","year":"2011","journal-title":"Semin. Intervent. Radiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3748\/wjg.v21.i4.1344","article-title":"Pulmonary embolism after arterial chemoembolization for hepatocellular carcinoma: An autopsy case report","volume":"21","author":"Hatamaru","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3748\/wjg.v22.i11.3127","article-title":"Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases","volume":"22","author":"Sag","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.14218\/JCTH.2016.00058","article-title":"Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels","volume":"4","author":"Schicho","year":"2016","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.3748\/wjg.v10.i19.2878","article-title":"Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level","volume":"10","author":"Li","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"ref_21","first-page":"1077","article-title":"High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: A prospective study","volume":"11","author":"Poon","year":"2004","journal-title":"Oncol. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jss.2006.10.054","article-title":"The effect of hepatic vascular inflow occlusion on liver tissue pH, carbon dioxide, and oxygen partial pressures: Defining the optimal clamp\/release regime for intermittent portal clamping","volume":"141","author":"Brooks","year":"2007","journal-title":"J. Surg. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jvir.2014.04.005","article-title":"Pharmacokinetics and antitumorefficacy of chemoembolization using 40\u03bcm irinotecan-loaded microspheresin a rabbit liver tumor model","volume":"25","author":"Tanaka","year":"2014","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_24","first-page":"2605","article-title":"Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated withactivation of irinotecan","volume":"8","author":"Xu","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.3748\/wjg.v12.i22.3546","article-title":"Cholangiocytes and blood supply","volume":"14","author":"Gaudio","year":"2006","journal-title":"World J. Gastroenterol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/3\/211\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:19:39Z","timestamp":1760163579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/3\/211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,20]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["curroncol28030211"],"URL":"https:\/\/doi.org\/10.3390\/curroncol28030211","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2021,6,20]]}}}